Search clinical trials for: Protein C Inhibitor

Total 69968 results

Virginia Commonwealth University
American Psychological Foundation

Recruiting

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors (C-SMART)

Brain Tumor | Mild Neurocognitive Disorder | Glioma, Mixed

United States
Aurealis Oy

Completed

Treatment of Diabetic Foot Ulcers With AUP1602-C

Diabetic Foot Ulcer

Germany, Poland
New York University

Withdrawn

New York University Falls Prevention Program

Falls Related Risk Factors in the Elderly

United States
Institute of Hematology & Blood Diseases Hospital

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Multiple Myeloma

China
Creative Peptides Sweden Inc.

Completed

Effect of C-Peptide on Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 1 | Diabetic Polyneuropathy

Sweden
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission

Acute Myeloid Leukemia

United States
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients

Dermatomyositis, Adult Type

China
Northwell Health
National Institute on Aging (NIA)

Recruiting

Reduce Loneliness in Care Partners of Persons With AD/ADRD

Loneliness

United States
Novoxel Ltd.

Completed

Efficacy and Safety of Tixel Treatment on Facial and/or Scalp Actinic Keratoses.

Actinic Keratoses

Israel
Eli Lilly and Company

Completed

A Study of LY3337641 in Healthy Male Participants

Healthy

United States
Institute of Hematology & Blood Diseases Hospital
Cellular Biomedicine Group Ltd.

Completed

A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy

Diffuse Large B Cell Lymphoma

China
University of Pittsburgh

Completed

Improving Sleep Health in Adults With Overweight or Obesity

Sleep Wake Disorders | Sleep Disorder | Sleep Disturbance

United States
Far Eastern Memorial Hospital

Completed

Clinical Outcome of Laparoscopic or Robotic Metroplasty for Uterine Isthmocele

Laparoscopic or Robotic Metroplasty

Taiwan
The University of Texas Health Science Center,...
Otto Bock Healthcare Products GmbH

Completed

Clinical Algorithm for Post-Stroke Gait Training With C-Brace

Hemiparesis Due to Stroke | Hemiplegia Due to Stroke

United States
University of California, San Francisco

Completed

Improving Access to Care: Testing an Integrated Care Mobile Health Intervention

Insomnia | Delayed Sleep Phase

United States
Peking Union Medical College Hospital
Cellular Biomedicine Group Ltd.

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Multiple Myeloma

China
Apifix

Completed

Feasibility Evaluation Study of the MID-C Device (MID-C)

Adolescent Idiopathic Scoliosis (AIS)

Israel
Dana-Farber Cancer Institute
University of Washington

Completed

Computerized Assessment for Patients With Cancer (ESRA-C)

Neoplasms

United States
University Medical Center Nijmegen

Unknown

A Trial to Assess the Effect and Safety of the C-Qur™ Film (CLIPEUS)

Postoperative Adhesions

Netherlands
UNC Lineberger Comprehensive Cancer Center
GlaxoSmithKline

Completed

LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations

Unresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant Melanoma

United States
National Cancer Institute (NCI)

Completed

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Childhood Solid Neoplasm

United States, Canada
Peking University People's Hospital
Cellular Biomedicine Group Ltd.

Unknown

C-CAR011 Treatment in Subjects With ALL After HSCT

Acute Lymphoblastic Leukemia(ALL)

China
Guangzhou University of Traditional Chinese Medicine

Unknown

Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine (Spchim)

Carotid Artery Plaque
Guangzhou University of Traditional Chinese Medicine
Liaoning Tumor Hospital & Institute; Zhongshan People's Hospital, Guangdong... and other collaborators

Unknown

Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117 (PRISIT)

Occlusion and Stenosis of Unspecified Cerebral Artery
Hannover Medical School

Completed

Efficacy Study of Temsirolimus to Treat Head and Neck Cancer (TEMHEAD)

Head and Neck Squamous Cell Carcinoma

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Videolaryngoscopic Intubation Using Macintosh vs.Hyperangulated Blades in Patients With Expected Difficult Intubation

General Anesthesia | Intubation; Difficult or Failed | Videolaryngoscopy

Germany
Hospital St. Joseph, Marseille, France

Completed

Screening for Chronic Hepatitis C Virus in Hospitalized Patients (DeViCHO)

Hepatitis C

France
Hospital de Clinicas Caracas
Tel Aviv University

Unknown

High Protein Breakfast on Postprandial Glycemia in T2D (PBD) (PBD)

Type 2 Diabetes
National Cancer Institute (NCI)

Completed

Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only

Recurrent Breast Carcinoma | Invasive Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7

United States
Sun Yat-sen University

Recruiting

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Liver Diseases | Hepatocellular Carcinoma | Immunotherapy | Camrelizumab | Lenvatinib

China
CSL Behring

Terminated

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Antibody-mediated Rejection

United States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital and other collaborators

Not yet recruiting

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Pfizer

Completed

Drug Drug Interaction Study Of Crizotinib With Esomeprazole.

Healthy

Belgium
National Cancer Centre, Singapore

Terminated

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Singapore
Sumitomo Pharma America, Inc.

Terminated

Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy

Acute Myeloid Leukemia (AML)

United States
Sun Yat-sen University

Recruiting

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Liver Diseases | Hepatocellular Carcinoma | Immunotherapy | Sintilimab | Lenvatinib

China
Avidia

Unknown

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Crohn's Disease

Australia
Shanghai Jiao Tong University School of Medicine

Recruiting

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Oral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFR

China
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Liver Cancer

United States
Bristol-Myers Squibb

Completed

A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

Healthy

Netherlands
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 2)

Hereditary Angioedema

United States
Shire

Completed

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

Hereditary Angioedema

United States
Michael Levy
ViroPharma

Completed

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Neuromyelitis Optica

United States
Liga Panamericana de Asociaciones de Reumatologia...

Recruiting

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (PREJAK)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis

Argentina
Bayer

Completed

Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer. (BASIL)

Carcinoma, Hepatocellular

Hong Kong, Taiwan, Korea, Republic of, Singapore
Jón Þór Trærup Andersen

Recruiting

Academic Detailing About Proton Pump Inhibitors (BRIEF-PI)

Prescription Pattern

Denmark
NYU Langone Health
CSL Behring

Completed

C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection

Antibody Mediated Rejection of Kidney Transplant

United States
William Shomali
Incyte Corporation

Recruiting

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Eosinophilia | Hypereosinophilic Syndrome | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Splenomegaly | Hepatomegaly | Chronic Eosinophilic Leukemia, Not Otherwise Specified | JAK2 Gene Mutation | BCR-JAK2 Fusion Protein Expression | Blasts 20 Percent or Less of Peripheral Blood White... and other conditions

United States
Hunan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Soft Tissue Sarcoma | Uterine Cancer | Advanced Non Small Cell Lung Cancer

China
National Cancer Institute (NCI)

Active, not recruiting

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...

United States

Search clinical trials for: Protein C Inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations